CSNK2B and neoplasm: Remarkably, in lymph nodes of 62% of MCL patients in our series (13/21 cases) both CK2α and CK2β were strongly expressed in tumor cells as compared to normal residual areas and their expression overlapped the expression pattern of Cyclin D1 (Figure 1, panels D-E-F).